Document:

Form of Performance Stock Unit Agreement

 EXHIBIT 10.1 
 PERFORMANCE STOCK UNIT AGREEMENT 
 This Performance
Stock Unit Agreement (this “Agreement”) is made as of March 15, 2010, by Eclipsys Corporation, a Delaware corporation (referred to in this Agreement, together with its affiliates and successors, as “Eclipsys”)
and                                  (“Recipient”) to govern the
performance stock unit award described herein. 
 In consideration of the provisions of this Agreement and other consideration,
the value and sufficiency of which is hereby acknowledged, Eclipsys and Recipient hereby agree as follows: 
 1. The Award
and Certain Definitions. 
 (a) The Award. Effective on the Grant Date, Eclipsys has granted to Recipient the
following performance stock unit award (the “Award”): 
 Subject to the terms and conditions set forth in this
Agreement and the Plan, as of the Vesting Date Eclipsys will become obligated to issue to Recipient the Earned Shares, if any. 
 The Award is a
contract right only and confers no voting or dividend rights or other attributes of stock ownership unless and until Earned Shares are issued pursuant hereto. 
 (b) Certain Definitions. For purposes of the Award, the following definitions apply: 
 (i) “Acceleration Event” means Recipient’s employment with Eclipsys terminates before the third anniversary of the Grant Date under circumstances described in
Section 4(a)(ii). 
 (ii) “Affiliate” means any entity that controls, is controlled
by, or is under common control with Eclipsys, and for this purpose “control” means ownership of more than half of the outstanding voting or economic interests. 
 (iii) “Change in Control” has the meaning set forth in the Plan. 
 (iv) “Earned Shares” means that number of Shares, determined as of the Measurement Date, equal to the
product of (i) the Nominal Amount, and (ii) the Performance Factor; but subject to adjustment as described in Section 4. 
 (v) “Grant Date” means March 15, 2010. 
 (vi)
“Measurement Date” means the Vesting Date unless an earlier Change in Control occurs, in which case the Measurement Date means the closing date of the Change in Control, as described in Section 4(c). 
 (vii) “Nominal Amount” means
                    . 
  

 1 

 (viii) “Performance Factor” is the factor calculated in the
manner described in Schedule A to this Agreement. 
 (ix) “Plan” means the Eclipsys
Corporation 2008 Omnibus Incentive Plan, as amended from time to time. 
 (x) “Shares” means
shares of Common Stock of Eclipsys. 
 (xi) “Vesting Date” means the third anniversary of the
Grant Date, provided that if an Acceleration Event occurs before the third anniversary of the Grant Date, then the Vesting Date means the date that Acceleration Event occurs. 
 2. Issuance of Earned Shares. 
 (a) Timing and Method of Issuance. Subject to Section 2(b) and Section 4(c), Eclipsys will issue any Earned Shares, net of the number of shares, if any, withheld by Eclipsys
in payment of tax pursuant to Section 3, to Recipient not later than 15 days following the Vesting Date. Any Earned Shares issued will be fully paid and non-assessable. The Earned Shares may be issued in book entry or certificated form,
in Eclipsys’ discretion, subject to any right of Recipient under applicable law to receive a stock certificate. 
 (b)
Conditions to Issuance. As a condition to issuance of the Earned Shares, Recipient must, if requested by Eclipsys, make appropriate representations in a form satisfactory to Eclipsys that such Earned Shares will not be sold other than
(A) pursuant to an effective registration statement under the Securities Act of 1933, as amended, or an applicable exemption from the registration requirements of such Act; (B) in compliance with all applicable state securities laws and
regulations; and (C) in compliance with all terms and conditions of the Plan, any applicable policy of Eclipsys, and any other written agreement between Recipient and Eclipsys. 
 3. Tax Matters. The issuance of the Earned Shares will generally result in taxable income for Recipient and is subject to appropriate
income tax withholding, deposits, or other deductions required by applicable laws or regulations. Subject to any separate written agreement between Recipient and Eclipsys, Recipient and Recipient’s successors will be responsible for all income
and other taxes payable as a result of grant of the Award or issuance of Earned Shares. All obligations of Eclipsys to pay tax deposits to any federal, state or other taxing authority as a result of the Award or issuance of Earned Shares will result
in a commensurate obligation of Recipient to reimburse Eclipsys the amount of such tax deposits. Eclipsys may in its discretion, but is not obligated to, require that some or all of such obligation of Recipient be satisfied by the Recipient
forfeiting and Eclipsys deducting and retaining from the Earned Shares such shares (or other consideration as described in Section 4(b)) with a value equal to the amount of the tax deposits that Eclipsys pays, with such value measured by
the same value per share used by Eclipsys to determine its tax deposit obligation and based on the minimum statutory withholding rates for federal and state income and payroll tax purposes that are applicable to supplemental wages. If Eclipsys is
required to pay additional tax deposits after the initial issuance to Recipient of the net number of Earned Shares, Eclipsys may require Recipient to provide reimbursement in cash. If the tax deposits paid 
  

 2 

 are less than Recipient’s tax obligations, Recipient is solely responsible for any additional taxes
due. If Eclipsys pays tax deposits in excess of Recipient’s tax obligations, Recipient’s sole recourse will be against the relevant taxing authorities, and Eclipsys will have no obligation to issue additional shares or pay cash to
Recipient in respect thereof. Recipient is responsible for determining Recipient’s actual income tax liabilities and making appropriate payments to the relevant taxing authorities to fulfill Recipient’s tax obligations and avoid interest
and penalties. 
 4. Termination of Employment; Change in Control. 
 (a) Termination of Employment. 
 (i) If Recipient’s employment with Eclipsys terminates before the Vesting Date as a result of termination by Eclipsys for Cause, or by Recipient without Good Reason, or under any other circumstances
other than as described in Section 4(a)(ii), the Award shall immediately terminate without partial or ratable vesting regardless of the amount of time elapsed from the Grant Date, no Shares or other consideration will be issued or
delivered to Recipient pursuant to the Award, and Recipient will have no further rights in respect of the Award.  
 (ii) If Recipient’s employment with Eclipsys is terminated by Eclipsys without Cause, or if Recipient terminates his employment with Good Reason, or Recipient’s employment terminates as a result
of the death of Recipient, then such termination of employment will constitute an Acceleration Event, the Vesting Date shall be the date that Acceleration Event occurs, and the Earned Shares shall be determined on a pro-rata basis by multiplying the
product described in Section 1(b)(iv) by a fraction, the numerator of which is the number of days from the Grant Date to and including the date that Acceleration Event occurs and the denominator of which is 1,095. Recipient will not
receive accelerated vesting or other credit of any kind for periods beyond the date the Acceleration Event occurs, and to the extent that any agreement between Eclipsys and Recipient or policy of Eclipsys provides otherwise, including but not
limited to any severance, employment or similar agreement between Eclipsys and Recipient providing for accelerated vesting of equity awards in connection with termination of Recipient’s employment, Recipient agrees that, as a condition to
receipt of the Award, that agreement or policy will not apply to the Award, and that agreement or policy is hereby amended to that effect. 
 (iii) Certain Definitions. For these purposes, Cause and Good Reason have the meanings set forth in Recipient’s employment agreement with Eclipsys as in effect at the time of determination,
and if Recipient has no employment agreement or Recipient’s employment agreement does not define Cause and/or Good Reason, then Cause and/or Good Reason, as the case may be, have the meaning set forth in the Plan. 
 (b) Exchange Consideration. 
 (i) In the event of a Change in Control or other reorganization or recapitalization of Eclipsys (collectively, a “Transaction”) in which holders of shares of common stock of Eclipsys are
entitled to receive in respect of such shares any additional, new or different 
  

 3 

 
shares or securities, cash or other consideration (“Exchange Consideration”), then subject to Section 4(b)(ii), Recipient will be entitled to receive, at the time any
Earned Shares would otherwise be issued pursuant to this Agreement but in addition to or lieu of such Earned Shares, as the case may be, the Exchange Consideration that would have been provided and/or retained in respect of the Earned Shares at the
time of the Transaction if the Earned Shares had been outstanding at that time. 
 (ii) If the Exchange
Consideration includes anything other than shares of common stock (“Non-Stock Consideration”), then Eclipsys or its successor may in its discretion replace some or all of the Non-Stock Consideration with common stock of Eclipsys or
its successor or a parent organization having a value equal to the replaced Non-Stock Consideration (“Replacement Consideration”), with the replaced Non-Stock Consideration and the Replacement Consideration valued in the same way as
in the Transaction. If there is no issuance of common stock like the Replacement Consideration in the Transaction, then the Replacement Consideration will be valued using the arithmetic mean of the closing price of a share of the common stock
included in the Replacement Consideration for the ten consecutive trading days ending on the closing date of the Transaction (or if the Transaction does not close on a trading day, then ending on the last trading day preceding the closing date of
the Transaction), and if the common stock included in the Replacement Consideration does not trade on a national securities exchange or market system providing for volume and liquidity sufficient, in the reasonable judgment of the board of directors
of Eclipsys or its successor, to establish a fair market value for the Replacement Consideration, then the Replacement Consideration shall be valued by the board of directors of Eclipsys or its successor in good faith . 
 (c) Change in Control. 
 (i) If a Change in Control occurs before the third anniversary of the Grant Date, the closing date of that Change in Control will be the Measurement Date but Recipient will not be entitled to have the
Earned Shares or the Exchange Consideration issuable in respect thereof pursuant to Section 4(b)(i) (or a ratable portion thereof as described in Section 4(a)(ii)) issued until the Vesting Date, and if a termination of
employment as described in Section 4(a)(i) occurs before the Vesting Date, the consequences described in Section 4(a)(i) will apply. 
 (ii) Notwithstanding Section 4(c)(i), in case of a Change in Control the board of directors of Eclipsys or its
successor, acting before or within 15 days after the closing of the Change in Control, may bifurcate the Award, in which case the first element of the Award will be governed by Section 4(c)(i) with respect to Earned Shares calculated
pursuant to Section 4(c)(i) but using a modified Nominal Amount equal to the product of the figure stated in Section 1(b)(vii) and a fraction, the numerator of which is the number of days from the Grant Date to and including
the closing date of the Change in Control and the denominator of which is 1,095. The second element of the Award will be governed by this Agreement but will (A) be based upon a new Nominal Amount equal to the difference between the figure
stated in Section 1(b)(vii) and the modified Nominal Amount used to determine the first element of the Award, (B) use a new Performance Period (as defined in 
  

 4 

 
Schedule A) from the date of closing of the Change in Control until the Vesting Date, and (C) be based upon the TSR (as defined in Schedule A) of the successor company in the
Change in Control (rather than Eclipsys) relative to the Comparison Group during the new Performance Period. 
 (iii) In case of a Change in Control that takes place pursuant to an agreement that is first publicly announced by Eclipsys or the other party to the agreement on or before December 15, 2010, for purposes of calculating the Earned
Shares, instead of the trailing average described in Section 2(e) of Schedule A the value of Eclipsys stock at the end of the Performance Period used to determine Eclipsys TSR will be the lesser of (A) the arithmetic mean of
the closing price of the stock on each of the 20 consecutive trading days ending on and including the last trading day immediately preceding the date of the first public announcement by Eclipsys or the other party thereto of the agreement pursuant
to which the Change in Control takes place; or (B) the value of Eclipsys stock in the Change in Control transaction. 
 (iv) In case of a Change in Control other than as described in Section 4(c)(iii), for purposes of calculating the Earned Shares, instead of the trailing average described in
Section 2(e) of Schedule A the value of Eclipsys stock at the end of the Performance Period used to determine Eclipsys TSR will be based upon the value of Eclipsys stock in the Change in Control transaction. 
 5. Additional Agreements 
 (a) Value of the Award or Earned Shares. There is no minimum number of Shares or other consideration that Recipient will receive, and the Award may result in no Shares or other consideration being
issued to Recipient. The maximum number of Shares (or equivalent value Exchange Consideration) that can be issued to Recipient pursuant to the Award is 2.25 times the Nominal Amount. No representations or promises are made to Recipient regarding the
value of the Award or any Earned Shares or Exchange Consideration or the business prospects of Eclipsys. Recipient acknowledges that information about investment in Eclipsys stock, including financial information and related risks, is contained in
Eclipsys’ SEC reports on Form 10-Q and Form 10-K, which have been made available from Eclipsys’s Human Resources department and/or on Eclipsys’s internal web site for Recipient’s review at any time before Recipient’s
acceptance of this Agreement or at any time during Recipient’s employment. Further, Recipient understands that Eclipsys and its employees, counsel and other representatives do not provide tax or investment advice and acknowledges Eclipsys’
recommendation that Recipient consult with independent specialists regarding such matters. Sale or other transfer of Eclipsys stock may be limited by and subject to policies of Eclipsys as well as applicable securities laws and regulations.

 (b) No Right to Continued Employment or Service; No Positive Inference. Neither this Agreement nor the Award or any
issuance of Earned Shares or Exchange Consideration confers upon Recipient any right to continue as an employee, director or consultant of, or in any other relationship with, Eclipsys, or to any particular employment or service tenure or minimum
vesting of the Award, or limits in any way the right of Eclipsys to terminate Recipient’s services to Eclipsys at any time, with or without cause. The Award is to motivate and reward future performance, and

  

 5 

 
will not be interpreted as a reward for past performance or an indication that Recipient has performed well or is entitled to any particular employment or service tenure. 
 (c) Remedy for Breach of Legal Obligations. As a condition to receipt of the Award and any issuance of Earned Shares or Exchange
Consideration, Recipient must enter into the Eclipsys Proprietary Interest Protection Agreement, in the form specified by Eclipsys. If Recipient breaches in any material respect the Proprietary Interest Protection Agreement between Recipient and
Eclipsys, or any other contract between Recipient and Eclipsys, or Recipient’s common law duty of confidentiality or trade secret protection, and Recipient fails to cure that breach in full within ten days of notice and demand for cure by
Eclipsys, then such breach shall entitle Eclipsys, in its discretion and in addition to any other legal or equitable remedies available to it, to do any or all of the following: 
 (1) Cancel and terminate the Award as of the date of such breach; 
 (2) recover from Recipient any Earned Shares or Exchange Consideration that may previously have been issued and are still
owned by Recipient, whereupon any rights of Recipient to such recovered shares will cease; 
 (3) require
Recipient to disgorge to Eclipsys the net income Recipient earned upon transfer by Recipient, at any time from 12 months before such breach until 12 months after Eclipsys learned of such breach, of any Earned Shares or Exchange Consideration, and
for this purpose net income means the value at time of transfer less applicable income taxes paid in connection with such shares; and/or 
 (4) obtain injunctive relief or other similar remedy in any court with appropriate jurisdiction in order to specifically enforce the provisions hereof. 
 (d) Governing Documents. The Award is granted pursuant to and, except as set forth herein or in another written agreement
between Eclipsys and Recipient, subject in all respects to, and Recipient agrees to be bound by, the Plan, which is incorporated herein by reference. In case of any conflict between this Agreement and the Plan, this Agreement shall control to the
extent that this Agreement includes provisions not specifically addressed in the Plan or relates to provisions of the Plan that by their terms are subject to the Award Document as defined therein, and otherwise the Plan shall control. Without
limiting the foregoing and for clarity, Section 11 of the Plan is subject to Section 4 of this Agreement. 
 (e)
Internal Revenue Code Section 409A. It is intended that this Agreement and the compensation and benefits hereunder either be exempt from, or comply with, Internal Revenue Code Section 409A, and this Agreement shall be so construed
and administered. If Eclipsys reasonably determines that any compensation or benefits awarded or payable under this Agreement may be subject to taxation under Section 409A, Eclipsys, after consultation with Recipient, shall have the authority
to adopt, prospectively or retrospectively, such amendments to this Agreement or to take any other actions it determines necessary or appropriate to: (i) exempt the compensation and benefits payable under this Agreement from Section 409A;
or (ii) comply with the requirements of Section 409A. In no event, however, shall this section or any other provision of the Plan or this Agreement be construed to require Eclipsys to provide any gross-up for the tax consequences of any

  

 6 

 
provisions of, or awards or payments under, this Agreement and Eclipsys shall have no responsibility for tax consequences of any kind, whether or not such consequences are contemplated at the
time of entry into this Agreement, to Recipient (or Recipient’s beneficiary) resulting from the terms or operation of this Agreement. 
 6. General. 
 (a) Notices. Any notices, demands or other
communications required or desired to be given by any party shall be in writing and shall be validly given to another party if served personally or if deposited in the United States mail, certified or registered, postage prepaid, return receipt
requested. If such notice, demand or other communication shall be served personally, service shall be conclusively deemed made at the time of such personal service. If such notice, demand or other communication is given by mail, such notice shall be
conclusively deemed given forty-eight (48) hours after the deposit thereof in the United States mail addressed to the party to whom such notice, demand or other communication is to be given as hereinafter set forth, provided that either party
may change its address for the purpose of receiving notices, demands and other communications by providing written notice to the other party in the manner described in this paragraph: 
 To Eclipsys: At Eclipsys headquarters, attention General Counsel 
 To Recipient: At Recipient’s address of record as maintained in Eclipsys’s employment files 
 (b) Entire Agreement. Except as this Agreement and/or another written agreement between Eclipsys and Recipient may expressly provide
otherwise, this Agreement and the Plan constitute the entire agreement and understanding of Eclipsys (together with its Affiliates) and Recipient with respect to the Award, and supersede all prior written or verbal agreements and understandings
between Recipient and Eclipsys (together with its Affiliates) relating to the Award. Recipient has not received and is not relying upon, and will not rely upon, any representations, assurances, or advice by any employee of or counsel to or other
representative of Eclipsys or any of its Affiliates in connection with this Agreement or the Award. This Agreement may only be amended by written instrument signed by Recipient and an authorized officer of Eclipsys. 
 (c) Governing Law; Severability. This Agreement will be construed and interpreted under the laws of the State of Delaware
applicable to agreements executed and to be wholly performed within the State of Delaware. If any provision of this Agreement as applied to any party or to any circumstance is adjudged by a court of competent jurisdiction to be void or unenforceable
for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision under circumstances different from those adjudicated by the court, the application of any other
provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole. If any provision of this Agreement becomes or is deemed invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration
of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or, if such provision cannot 
  

 7 

 be so amended without materially altering the intention of the parties, then such provision will be stricken
and the remainder of this Agreement shall continue in full force and effect. 
 (d) Remedies. All rights and remedies
provided pursuant to this Agreement or by law shall be cumulative, and no such right or remedy shall be exclusive of any other. A party may pursue any one or more rights or remedies hereunder or may seek damages or specific performance in the event
of another party’s breach hereunder or may pursue any other remedy by law or equity, whether or not stated in this Agreement. 
 (e) Disputes. Any claim under this Agreement must be commenced by a claimant within 365 days of the date on which the cause of action accrues (unless a contractual limitation on duration of claims is impermissible or a longer
period of time is required by law, in which case the end of the minimum required period will be the deadline for commencing claims), or it will be deemed waived. Any and all disputes and claims between Recipient and Eclipsys that arise out of this
Agreement or relate to the Award shall be resolved exclusively by final and binding arbitration conducted before a single arbitrator in accordance with the then existing Rules and Regulations of the American Arbitration Association. The arbitration
will be conducted within 50 miles of Recipient’s home, provided that if Recipient and other individuals receiving awards similar to the Award have substantially the same claims, then Recipient and any or all of such other individuals may, in
their discretion, have their arbitrations consolidated for efficiency and conducted in a location that they jointly determine. Recipient and Eclipsys understand and agree that the arbitration shall be instead of any civil litigation and that this
means that Recipient and Eclipsys are waiving right to a jury trial as to such claims. The parties shall be entitled to conduct adequate discovery and to obtain all remedies available to the parties as if the matter had been tried in court
(including, without limitation, the award of attorneys’ fees to the prevailing party if authorized by statute). The arbitrator shall issue a written decision which specifies the findings of fact and conclusions of law on which the
arbitrator’s decision is based. The decision of the arbitrator shall be final and binding on all parties (and shall be subject to judicial review as required by law), and may be entered as a judgment by either Recipient or Eclipsys with any
federal or state court of competent jurisdiction. The parties shall pay their own costs of arbitration; provided, however, Eclipsys shall pay such costs of arbitration to the extent it is required to do so to make this agreement enforceable, and
provided further that the prevailing party in any dispute shall be entitled to recover his or its reasonable fees and costs incurred in connection with such action from the non-prevailing party, including without limitation fees and cost of
attorneys and experts. 
 (f) Interpretation. Headings herein are for convenience of reference only, do not
constitute a part of this Agreement, and will not affect the meaning or interpretation of this Agreement. References herein to Sections are references to the referenced Section hereof, unless otherwise specified. 
 (g) Waivers; Amendments. Eclipsys may waive any provision of this Agreement in any instance to the extent the waiver does not
adversely affect Recipient in any material way. The waiver by either party of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any later breach of that provision. This Agreement may be modified only by
written agreement signed by Recipient and Eclipsys. 
  

 8 

 (h) Counterparts. This Agreement may be executed in more than one counterpart,
each of which shall be deemed an original, but all of which together shall constitute but one and the same instrument. Facsimile or photographic copies of originally signed copies of this Agreement will be deemed to be originals. 
  

			
	ECLIPSYS CORPORATION	  	
		
		  	  

	By:	  	Name of Recipient
	Name:	  	
	Title:	  	  

		  	Signature of Recipient

  

 9 

 Schedule A to Performance Unit Agreement 
 1. Calculation. The Performance Factor for purposes of the Award will be calculated as follows: 
 FIRST: 
 For Eclipsys and for each
other company in the Comparison Group, determine the Total Shareholder Return for the Performance Period. 
 SECOND: 
 Rank the TSRs determined in the first step from low to high (with the company having the lowest TSR being ranked number
1, the company with the second lowest TSR ranked number 2, and so on) and determine the Eclipsys percentile rank based upon its position in the list by dividing Eclipsys’ position by the total number of companies (including Eclipsys) in the
Comparison Group and rounding the quotient to the nearest hundredth. For example, if Eclipsys were ranked 42nd on the list out of 74 companies, its percentile rank would be 42/74 or 56.76%. 
 THIRD: 
 Plot the percentile rank
for Eclipsys determined in the second step into the appropriate band in the left-hand column of the table below and determine the Performance Factor, which is the figure in the right-hand column of the table below corresponding to that percentile
rank. Use linear interpolation between points in the table below to determine the percentile rank and corresponding Performance Factor if Eclipsys’ percentile rank is greater than 25% and less than 90% but not exactly one of the percentile
ranks listed in the left-hand column. For example, if Eclipsys’ percentile rank is 56.76%, the Performance Factor would be 1.2704. 
  

			
	 Percentile Rank
	  	Performance Factor
	 25% and below
	  	0
	 37.5%
	  	0.5
	 50%
	  	1.0
	 60%
	  	1.4
	 70%
	  	1.8
	 75%
	  	2.0
	 90% and above
	  	2.25

 2. Rules and Definitions. The
following rules and definitions apply to the computation of the Performance Factor: 
 a. “Comparison Group”
means Eclipsys and the other companies listed on Appendix 1 to this Schedule A, as may be adjusted pursuant to Section 2(f) below. 
  

 10 

 b. “Performance Period” means the period beginning on the Grant Date and
ending on the Measurement Date. 
 c. “Total Shareholder Return” or “TSR” means total
shareholder return as calculated by S&P Compustat, and if that service is not available, then by another widely recognized commercial service selected by the Eclipsys Board of Directors or a committee thereof. 
 d. The minimum Performance Factor is zero and the maximum Performance Factor is 2.25. There is no minimum number of Shares or other
consideration that Recipient will receive, and a Performance Factor of zero will result in no Earned Shares or other consideration being issued. 
 e. For purposes of computing Total Shareholder Return for Eclipsys and each other company in the Comparison Group, the stock price at the beginning and end of the Performance Period will, subject to
Section 4(c), be determined as the arithmetic mean of the closing price of the stock on each of the 20 consecutive trading days ending on and including the first day or last day of the Performance Period, as the case may be. 

f. Companies shall be removed from the Comparison Group if they undergo a Specified Corporate Change. A company that is removed from the
Comparison Group before the Measurement Date will not be included at all in the computation of the Performance Factor. A company in the Comparison Group will be deemed to have undergone a “Specified Corporate Change” if it: 
  

	 	1.	ceases to be a domestically domiciled publicly traded company on a national stock exchange or market system, unless such cessation of such listing is due to a low stock
price or low trading volume; or 

	 	2.	files for bankruptcy, liquidation or reorganization; or 

	 	3.	is the subject of an involuntary bankruptcy proceeding that is not dismissed within 30 days; or 

	 	4.	ceases to conduct substantial business operations; or 

	 	5.	is the subject of a stockholder-approved plan of liquidation or dissolution; or 

	 	6.	has gone private; or 

	 	7.	has reincorporated in a foreign (e.g., non-U.S.) jurisdiction, regardless of whether it is a reporting company in that or another jurisdiction; or

	 	8.	has been acquired by another company (whether by a peer company or otherwise, but not including internal reorganizations), or has sold all or substantially all of its
assets; or 

	 	9.	changes, through evolution, acquisition activity, or otherwise, such that less than half of its revenue is derived from business operations classified in GICS code
351030 (Health Care Tech.) or 451030 (Software) (or their successor codes). 

 Eclipsys shall rely on press releases, public
filings, website postings, and other reasonably reliable information available regarding a peer company in making a determination that a Specified Corporate Change has occurred. 
  

 11 

 Appendix 1 to 
 Schedule A to 
 Performance Stock Unit Agreement 

 Comparison Group 
  

																			
	 Company
	  	1/31/2010
Mkt. Cap.	  	L4Q
Revenue	  	GICS Industry	  	 Company
	  	1/31/2010
Mkt. Cap.	  	L4Q
Revenue	  	GICS Industry
	 Allscripts-Misys Healthcare
	  	$2,403	  	$661	  	351030	  	Health Care Tech.	  	NetSuite Inc.	  	$985	  	$165	  	451030	  	Software
	 Quality Systems
	  	$1,476	  	$279	  	351030	  	Health Care Tech.	  	Blackbaud Inc.	  	$985	  	$313	  	451030	  	Software
	 SXC Health Solutions
	  	$1,413	  	$1,288	  	351030	  	Health Care Tech.	  	Lawson Software	  	$982	  	$713	  	451030	  	Software
	 AthenaHealth
	  	$1,325	  	$179	  	351030	  	Health Care Tech.	  	Advent Software	  	$969	  	$268	  	451030	  	Software
	 MedAssets
	  	$1,145	  	$329	  	351030	  	Health Care Tech.	  	Commvault Systems	  	$892	  	$243	  	451030	  	Software
	 Eclipsys
	  	$950	  	$518	  	351030	  	Health Care Tech.	  	MicroStrategy Inc.	  	$857	  	$367	  	451030	  	Software
	 Phase Forward
	  	$633	  	$205	  	351030	  	Health Care Tech.	  	Aspen Technology	  	$841	  	$265	  	451030	  	Software
	 Computer Prog. & Sys.
	  	$413	  	$126	  	351030	  	Health Care Tech.	  	WebSense	  	$811	  	$312	  	451030	  	Software
	 Omnicell
	  	$382	  	$221	  	351030	  	Health Care Tech.	  	ArcSight	  	$802	  	$156	  	451030	  	Software
	 Medidata Solutions
	  	$380	  	$134	  	351030	  	Health Care Tech.	  	Mentor Graphics	  	$788	  	$808	  	451030	  	Software
	 Medquist
	  	$257	  	$313	  	351030	  	Health Care Tech.	  	Taleo Corp.	  	$779	  	$196	  	451030	  	Software
	 Ansys
	  	$3,713	  	$502	  	451030	  	Software	  	Take-Two Interactive Software	  	$772	  	$968	  	451030	  	Software
	 Sybase
	  	$3,316	  	$1,144	  	451030	  	Software	  	Ultimate Software Group	  	$737	  	$194	  	451030	  	Software
	 Synopys
	  	$3,134	  	$1,360	  	451030	  	Software	  	Tyler Technologies	  	$655	  	$286	  	451030	  	Software
	 Rovi Corp.
	  	$2,975	  	$464	  	451030	  	Software	  	Netscout Systems	  	$571	  	$255	  	451030	  	Software
	 Factset Research Systems
	  	$2,968	  	$622	  	451030	  	Software	  	Sourcefire	  	$561	  	$94	  	451030	  	Software
	 Solera Holdings
	  	$2,305	  	$565	  	451030	  	Software	  	ACI Worldwide	  	$545	  	$389	  	451030	  	Software
	 Micros Systems
	  	$2,277	  	$880	  	451030	  	Software	  	Synchronoss Technologies	  	$520	  	$124	  	451030	  	Software
	 Informatica
	  	$2,119	  	$474	  	451030	  	Software	  	EBIX Inc.	  	$492	  	$87	  	451030	  	Software
	 Condur Technologies
	  	$1,957	  	$248	  	451030	  	Software	  	Deltek Inc.	  	$489	  	$267	  	451030	  	Software
	 Parametric Technology
	  	$1,948	  	$956	  	451030	  	Software	  	Manhattan Associates	  	$472	  	$260	  	451030	  	Software
	 Henry (Jack) & Assoc.
	  	$1,860	  	$745	  	451030	  	Software	  	Epicor Software	  	$471	  	$420	  	451030	  	Software
	 Compuware
	  	$1,749	  	$916	  	451030	  	Software	  	Bottomline Technologies	  	$448	  	$139	  	451030	  	Software
	 Cadence Design Systems
	  	$1,562	  	$860	  	451030	  	Software	  	EPIQ Systems	  	$432	  	$248	  	451030	  	Software
	 Quest Software
	  	$1,556	  	$702	  	451030	  	Software	  	SonicWALL	  	$413	  	$201	  	451030	  	Software
	 Novell Inc.
	  	$1,552	  	$862	  	451030	  	Software	  	Renaissance Learning	  	$390	  	$122	  	451030	  	Software
	 Tibco Software
	  	$1,519	  	$621	  	451030	  	Software	  	Radiant Systems	  	$383	  	$285	  	451030	  	Software
	 Blackboard Inc.
	  	$1,283	  	$362	  	451030	  	Software	  	TeleCommunication Systems	  	$370	  	$289	  	451030	  	Software
	 Solarwinds
	  	$1,265	  	$108	  	451030	  	Software	  	Descartes Systems Group	  	$364	  	$71	  	451030	  	Software
	 Pegasystems
	  	$1,220	  	$250	  	451030	  	Software	  	Rosetta Stone	  	$362	  	$240	  	451030	  	Software
	 SuccessFactors
	  	$1,166	  	$144	  	451030	  	Software	  	THQ Inc.	  	$340	  	$872	  	451030	  	Software
	 Progress Software
	  	$1,130	  	$497	  	451030	  	Software	  	Monotype Imaging Holdings	  	$313	  	$96	  	451030	  	Software
	 Ariba
	  	$1,121	  	$339	  	451030	  	Software	  	S1 Corp.	  	$312	  	$238	  	451030	  	Software
	 Fortinet
	  	$1,110	  	$240	  	451030	  	Software	  	Interative Intelligence	  	$299	  	$131	  	451030	  	Software
	 JDA Software Group
	  	$1,058	  	$386	  	451030	  	Software	  	VASCO Data Security Int’l.	  	$298	  	$99	  	451030	  	Software
	 Fair Isaac
	  	$1,035	  	$619	  	451030	  	Software	  	Smith Micro Software	  	$259	  	$104	  	451030	  	Software
	 Tivo Inc.
	  	$991	  	$230	  	451030	  	Software	  	Sonic Solutions	  	$255	  	$110	  	451030	  	Software

  

 12Selling Agreement

 Exhibit 10.2 
 Phoenix Life Insurance Company 
 INDEPENDENT PRODUCER CONTRACT    IP/BD 
 THIS CONTRACT made and entered into by and between PHOENIX LIFE
INSURANCE COMPANY, Administrative Offices, One American Row, Hartford, Connecticut, hereinafter referred to as the “Company” and         INVESTORS CAPITAL
CORPORATION         city of         LYNNFIELD        , State of
        MA         hereinafter referred to as “You”, and, if applicable, who is either a Broker-Dealer (herewith “Broker-Dealer”) or a
Registered Representative or associated person or entity of the undersigned Broker-Dealer or WS Griffith & Co., Inc., (hereafter “WS Griffith”) shall be effective the         1st         day of         DECEMBER         ,
        2002        . 
 This contract
includes the following terms and conditions: 
  

					
	 Basic Contract Provisions
	 	OL265 )A	  	(6-01)
	 Compliance and Sales Practices Provisions
	 	OL265 )B	  	(8-98)
	 Business Entity Provisions
	 	OL265 )C	  	(12-99)
	 Variable Products Provisions
	 	OL265 )D	  	(12-99)
	 Provisions for Contracting of Producers
	 	OL265 )F	  	(8-98)
	 Compensation Provisions
	 	OL265 )E	  	(6-01)
	 Expense Allowance Schedule
	 	OL272 )B	  	(4-01)

 THIS CONTRACT IS EXECUTED IN DUPLICATE AT
        LYNNFIELD, MA          on the         1st          day of         DECEMBER        ,         2002        .

  

							
	 INVESTORS CAPITAL CORPORATION
	 		 	By	 	 [ILLEGIBLE SIGNATURE]

	Broker-Dealer (if other than Producer)	 		 		 	
			
	 ICC INSURANCE AGENCY, INC
	 		 	             306.3

	Producer ([ILLEGIBLE])	 		 	NASD CRD NUMBER
				
	 [ILLEGIBLE SIGNATURE]
	 		 	Date	 	  

	Witness (Signature)	 		 		 	

 PHOENIX LIFE INSURANCE COMPANY 
 Note: This contract is not valid until approved by an executive officer of the Company. 
  

									
	Approved	 	 /s/ Dora D. Young
	 		 	Producer Code Number	 	 025705

				
	Date	 	 PRESIDENT
	 		 	

 

 
 © 2001 Phoenix Life Insurance Company - All Rights Reserved
  

  

					
	[ILLEGIBLE]	  	[ILLEGIBLE]	  	[ILLEGIBLE]

 BASIC CONTRACT PROVISIONS 
  

	1.	INTRODUCTION AND AUTHORITY 

  

	 	(a)	Authority to act as Producer is hereby granted to You, Provided You are duly licensed, You are free to solicit applications for all coverages offered by the Company,
deliver the policies, collect and submit the first premiums to the Company thereon, and service said business subject to the terms of this contract and regulations and procedures of the Company. 

  

	 	(b)	Nothing contained herein is intended to create the relationship of employer and employee between You and the Company. You are an independent contractor. You shall be
free to exercise Your own judgment as to the persons from whom You will solicit applications and the time, place and means of performing all acts hereunder. 

  

	 	(c)	This contract and Your conduct hereunder are subject to such regulations and procedures as the Company has established or may hereafter establish covering the conduct
of its business. 

  

	 	(d)	You acknowledge and agree that this contract, and Your conduct thereunder, are subject to such applicable federal or state laws, statutes and regulations or directives
issued by any regulatory entity having jurisdiction over the matters covered in this contract, including without limitation the rules and regulations of the Securities and Exchange Commission (SEC); the rules of the National Association of
Securities Dealers Inc. (NASD); the rules of the Broker-Dealer with which You are associated; the Interagency Statement on Retail Sales of Nondeposit Investment Products issued by Federal banking regulators on February 15, 1994 also known as
the “Interagency Statement” as may be amended from time to time. 

  

	 	(e)	You will cause and require all employees or Sub-producers associated with You to comply with all federal or state laws, statutes and regulations or directives issued by
any regulatory entity having jurisdiction over the matters covered by this contract, including the procurement of all prescribed licenses and including without limitation the rules and regulations of the SEC; the rules of the NASD; the rules of the
Broker-Dealer with which You are associated; the Interagency Statement on Retail Sales of Nondeposit Investment Products issued by Federal banking regulators on February 15, 1994 also known as the “Interagency Statement” as may be
amended from time to time. 

  

	2.	LIMITATIONS ON AUTHORITY 

  

	 	(a)	You shall not assign Your rights under this contract; make, alter or discharge contracts for the Company; or waive forfeiture; grant permits, name special rates;
guarantee dividends; or bind the Company in any way. 

  

	 	(b)	No circular; advertisement; materials to be used in any sales presentation; brochures; form letters; or any similar sales materials for the sale of Company products
shall be printed, published, or used in any way by You unless it shall first have been approved by the Company, and as appropriate, by the NASD and the Broker-Dealer with which You are associated with. 

  

	 	(c)	You shall not make any oral or written statements concerning the products offered under this Contract which may misrepresent any statements that are contained in the
current prospectuses or sales literature approved by the Company. 

  

	 	(d)	Only illustrations or proposals produced by the use of the Company’s approved illustration process or software may be used in connection with any sales
presentation. 

  

	3.	ADMITTED ACCOUNTS 

 Upon
receipt from the Company of any written statement of account, You agree to examine the same immediately and to notify the Company at once in writing of any difference between said statement and Your records. If You fail to notify the Company within
thirty (30) days of any difference, it shall be an admission of the correctness of such statement. 
  

	4.	COMPANY PROPERTY 

 All
printed matter, policyholder or account holder and premium information and records, proposal software, or any other supplies and equipment furnished by the Company to You in connection with the sale and solicitation of the products covered by this
Contract, are the property of the Company and must be returned upon termination of this Contract. You will assist the Company in the distribution and retrieval, from any employee or Sub-producer if necessary, of these materials at the Company’s
request. You are responsible for any misuses thereof of such property. All not taken policies, delivery receipts, initial premium receipts, temporary insurance receipts and any other receipts shall be returned to the Company on demand. 

 

					
	OL2650A 6-01	  	1	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 You will not disclose to any person, firm, or corporation, or utilize or reproduce for Your
own use, any proprietary information concerning the business of the Company which You may have acquired in the course of, or as an incident to, its services under this Contract. Proprietary information shall include, but not be limited to, proposal
formats, underwriting rules, product specifications and contract language, marketing information and materials, administrative procedures, computer systems and software, sales data, customer lists, financial plans, investment strategies,
policyholder and insured data, and Company data on agencies and distribution systems. The foregoing notwithstanding, the following shall not be considered proprietary information for the purposes of this provision: (a) information publicly
available or generally known within the life insurance industry; and (b) information obtained from other sources not under a duty of confidentiality to the Company with respect to such information. 
 You acknowledge and agree that the Company, either in its own right or through one or more subsidiaries and/or affiliates, is the sole owner
of the names, logos, symbols, trademarks, service marks, trade names or other means of identification (collectively, “Phoenix Marks”) now, heretofore or hereafter used by the Company, its subsidiaries and affiliates, whether or not such
subsidiaries or affiliates are wholly owned. You agree not to use any Phoenix Marks or variation thereof, including, without limitation, “Phoenix Life Insurance Company” and “Phoenix,” except as expressly authorized by Phoenix.
Any use by You of a Phoenix Marks shall be pursuant to this non-exclusive license, shall inure to the benefit of the Company and is subject to the right of the Company to approve or disapprove any such use, or withdraw any previous approval, in the
Company’s sole discretion. You agree not to raise or cause to be raised during the term of this Agreement or after its termination, on any grounds whatsoever, any questions concerning or challenges to the ownership by the Company of the Phoenix
Marks or the validity or registrability of the Phoenix Marks. You also agree that you shall cease all use of the Phoenix Marks in the event this agreement is terminated on any grounds whatsoever. This provision shall survive the termination of this
contract. 
  

	5.	MAINTAINING PRIVACY OF NON-PUBLIC PERSONAL INFORMATION 

  

	 	(a)	Definition 

 The term Non-Public
Personal Information (“NPPI”) means a customer’s or client’s private information as defined under either federal or state law or regulation. At a minimum, NPPI includes a customer’s name, telephone or facsimile number,
social security number, net worth, other financial information, any medical information and the fact that the customer has purchased a product or service from Phoenix. NPPI includes any such information obtained by You whether You obtain it in
connection with an application for, or servicing of, a Phoenix product or service or otherwise. 
  

	 	(b)	Obligations 

 You are obligated
to maintain the confidentiality of any NPPI that You obtain in connection with the sale and servicing of Company products under this contract. You will not divulge or release any NPPI in any manner except as permitted by law, or authorized in
writing by the owner of such NPPI. You will use such information only to the extent required in connection with the sale and servicing of this business and will not otherwise share it with any other person or organization. In the event that you
share NPPI with an entity assisting you in performing services under this contract, you must have an agreement with such entity which includes a confidentiality provision prohibiting disclose or use of NPPI other than to carry on the purposes for
which the information was provided. 
  

	 	(c)	Multiple relationship circumstances 

 Where You acquire NPPI that will be used in connection either with another company’s product, or in circumstances where it will be used with a Phoenix product or service in combination with other products or services (including any
such services which may be solicited by You) then You must comply with the privacy requirements of all such organizations. 
  

	6.	INDEBTEDNESS/INDEMNIFICATION 

 You agree to indemnify the Company for any indebtedness or obligations created by You or employees or Sub-producers associated with You, whether arising hereunder or otherwise. You also agree to indemnify the Company for any liabilities,
losses, costs or expenses incurred or moneys paid by the Company to any person as the result of the misrepresentations, negligence or unauthorized acts by You, Your employees or Sub-producers associated with You. 
  

					
	OL2650A 6-01	  	2	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 The Company, in addition to the rights available under the law to recover any funds due it,
may set off such obligation or indebtedness from any compensation payable under this contract or any other contract that You may have with the Company or with any affiliate or subsidiary of the Company. In addition You agree to reimburse the Company
for any attorney’s fees, expenses or collection costs incurred in the enforcement of this provision. The terms of this provision shall not be impaired by termination of this contract. 
 The Company will not indemnify You in any manner for any acts arising out of the operation of this contract. 
  

	7.	COLLECTION OF MONEYS - ACCOUNTING 

 You shall not accept cash currency for or on behalf of the Company, All funds received or collected by You, Your employees or Sub-producers associated with You, for or on behalf of the Company, shall be held in trust and shall not be used
for any personal use or other purposes whatsoever, but shall be immediately paid and delivered to the Company. You shall make such accounting as the Company may require for all funds, checks, money orders, drafts, policies, receipts and other
valuable papers received in connection with the business of the Company. You shall indemnify the Company for any losses resulting from receipt of money paid in connection with such insurance or annuity application or policy or receipts. 

 

	8.	ASSIGNMENTS 

 You shall
not assign compensation payable hereunder without the prior written consent of the Company. The Company does not assume responsibility for the validity or sufficiency of any aspect of any assignment. 
  

	9.	MODIFICATION OF CONTRACT 

 This entire contract may be modified in whole or in part from time to time through standard Company communication procedures. Any modifications of the contract made after the date on the forms contained in Your contract shall govern. Such
modifications are available for inspection at the Company’s local field offices or at the Home Office of the Company. Neither this contract nor any modification shall be binding on the Company unless approved in writing by an executive officer
of the Company. 
  

	10.	PRIOR CONTRACTS 

 This
contract replaces any previous contract with the Company and constitutes the entire agreement between You and the Company. Any obligation to the Company incurred by You under a prior contract shall continue to exist subject to the terms of such
prior contract. 
  

	11.	TERMS SUBJECT TO APPLICABLE LAW 

 All rights, powers, and remedies provided herein may be exercised only to the extent that the exercise thereof does not violate any applicable provision of law, and are intended to be limited to the extent necessary so that they will not
render this contract invalid, illegal, or unenforceable. If any term of this contract shall be held to be invalid, illegal, or unenforceable, the validity of other terms of this contract shall in no way be affected thereby. 
  

	12.	OBLIGATIONS 

 You
acknowledge that the Company relies upon You for a careful and frank presentation of the facts necessary for the proper underwriting and acceptance of the requested insurance coverages. You shall give complete and accurate answers in the application
and associated forms. You shall promptly transmit to the Company any and all information that will enable the Company to determine if the insurance applied for should be issued by the Company and upon what terms and rates. You shall not accept any
payment unless the applicant is at time of delivery in good health and in insurable condition as originally represented to us by the applicant to the best of Your knowledge and belief. 
  

	13.	BONDS/ERRORS AND OMISSIONS COVERAGE 

 The Company, at its option, or regulatory authorities, may require that You be bonded. Failure by You to be accepted for such bond or subsequent cancellation of the same shall terminate this contract. You
shall also obtain and maintain errors and omissions professional liability coverage in such an amount and in such forms as will be required by the Company. Copies of said coverages together with evidence of payment of any premiums or cost shall be
provided to the Company. Failure to provide such coverage or subsequent cancellation of the same shall terminate this contract. 
  

					
	OL2650A 6-01	  	3	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

	14.	PRESERVATION OF BUSINESS 

 For a period of two (2) years following the termination of this Contract for any reason, You shall not directly or indirectly contact any policy, account or annuity holder of the Company, for the purpose of inducing or attempting to
induce such a policy, account or annuity holder to surrender, cancel, lapse, or fail to renew such policy or policies, accounts or annuities with the Company. 
 Violation of this provision may be enjoined by any remedies, legal or equitable, available to the Company, including an injunction. In addition, the Company shall be entitled to recover from You all costs
and expenses including but not limited to all attorney fees incurred in connection with the enforcement of this provision. 
  

	15.	PERSISTENCY AND PRODUCTION REQUIREMENTS 

 The Company may from time to time establish minimum persistency and production requirements in order for You to continue this contractual relationship with the Company in order to receive certain
compensation levels as specified in this contract. Your failure to meet such requirements may terminate this Contract. 
  

	16.	FORBEARANCE NOT WAIVER 

 The failure of the Company to enforce any provision of this contract shall not constitute a waiver by the Company of any such provision. The past waiver of a provision by the Company shall not constitute a course of conduct or a waiver in
the future of that same provision. 
  

	17.	DUTIES UPON TERMINATION 

 Upon termination, You are under an absolute duty to return to the Company all Company property as set forth in this contract. You further acknowledge that You may not resist or impede in any manner the Company’s access to its policy,
account or annuity holders. 
 You further agree to immediately cease and desist from exercising any and all rights herein or
hereafter granted to You by the Company, including, without limitation, any right to use a Phoenix Mark(s). 
  

	18.	TERMINATION 

 This
contract, and the agency created hereunder, shall terminate on the occurrence of any of the following events and upon such termination all compensation shall cease, except as may be otherwise expressly provided herein: 
  

	 	(a)	Upon written notice of termination by You or the Company, with or without cause, either delivered personally or mailed to the last known address of the other party at
least twenty (20) days prior to the date fixed therein for such termination, unless an earlier date of termination satisfactory to both parties is specified, in which event such earlier date shall control. 

  

	 	(b)	If You are an individual, upon Your death. 

  

	 	(c)	Immediately if You withhold, convert, or misappropriate any moneys, policies, receipts or property belonging to the Company, its affiliates or subsidiaries or policy,
account or annuity holder; or breach any of the terms of this contract; violate any Company regulations or procedures. 

  

	 	(d)	Immediately upon the entry, involvement, or participation in any business activity by You which is in conflict with the interest of the Company as determined solely by
the Company. 

  

	 	(e)	If You fail to meet any minimum persistency or production requirements that may be established by the Company. 

  

	 	(f)	Immediately if You fail to obtain or maintain any bond or errors and omissions coverages that may be required by the Company. 

  

	 	(g)	Immediately if You are a partnership, corporation, or an individual operating under a trade name and there is a sale, merger, dissolution, bankruptcy or other transfer
of the assets of said corporation, partnership or entity. 

  

	 	(h)	Immediately if You fail to report any investigations or examinations commenced by any regulatory authorities relating to Your marketing and sales practices or fail to
cooperate with the Company in the investigation of any complaint or grievance brought against You. 

  

					
	OL2650A 6-01	  	4	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

	 	(i)	Immediately if You cease to be validly licensed as an insurance agent or producer. 

  

	 	(j)	Upon termination of any contractual relationship You may have with any affiliate, subsidiary or the parent of the Company. 

  

	19.	MISCELLANEOUS 

 The
headings to the paragraphs in this contract are only inserted as a guide to assist in the location of said paragraphs and they are not to be construed as any indication of the meaning or content of the respective paragraphs. 
  

					
	OL2650A 6-01	  	5	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 COMPLIANCE AND SALES PRACTICES PROVISIONS 
  

	1.	GENERAL 

 You will take
reasonable steps to ensure that You, Your sub-producers and/or employees make recommendations based upon reasonable grounds that the products being solicited are suitable and consistent with the applicants’ insurable needs and financial
objectives. 
 The determinations of suitability will include but not be limited to a reasonable inquiry as to the
applicants’: 
  

	 	•	 	 insurance and investment objectives 

  

	 	•	 	 financial situation 

  

	 	•	 	 risk propensity 

  

	 	•	 	 personal desires and needs, 

 The foregoing is not intended to replace or supersede any otherwise applicable insurance or securities suitability standards as may be applicable. 
  

	2.	REBATING AND DISCRIMINATORY TREATMENT 

 You will not directly or indirectly participate in any arrangement, plan or scheme that involves rebating of any compensation; the providing of any special benefit; or the giving of any other advantage to
a policy, account; annuity holders or insureds that is not made available to all policy, account or annuity holders and insureds. 
  

	3.	APPLICATION PROCEDURES 

 You shall have all applications and related documents for the products offered under this Contract accurately completed and signed by the applicant and properly witnessed. You shall submit the applications and related documents to the
Company directly or through the Broker-Dealer, if appropriate, together with all payments received from the applicant, without any deductions. You shall not accept any cash currency for or on behalf of the Company. You shall cause all checks or
money orders to be made payable to “Phoenix Life Insurance Company” and cause all payments collected for the Company to be held in trust and immediately delivered to the Company, Phoenix Equity Planning Corporation (hereinafter PEPCO) or
Broker-Dealer as appropriate. You shall also comply with any other application procedures that may be established from time to time by the Broker-Dealer, PEPCO or the Company. 
  

	4.	COMPLAINT OR GRIEVANCE HANDLING 

 Upon receipt of any written or oral complaint or grievance from a policy, account or annuity holder of the Company, You will immediately advise the Policyholder Service Center of the Company of the complaint or grievance. You agree that You
will fully cooperate with the Company in its investigation of the matter. This cooperation shall include, but not be limited to, responding to any requests for information, providing any needed statements and supplying copies of Your file on the
matter that is the subject of the complaint or grievance. You have no authority to settle or resolve the complaint or grievance involving a product issued by the Company. 
  

	5.	CONTINUING DUTY TO REPORT AND DISCLOSE 

 At the time of Your contracting with the Company, You provided certain information concerning You and Your Sub-producers, or employees’ background and suitability to be contracted and appointed to
represent the Company. You will immediately notify the Individual Compliance Department of the Company if there is any change in such information previously submitted. 
  

	6.	NOTIFICATION OF ANY EXAMINATION, INVESTIGATION OR LITIGATION 

 You will immediately notify the General Counsel of the Company of any investigations or examinations commenced by any regulatory authorities relating to any aspect of Your marketing and sales practices,
or that of Your Sub-producers or employees. You further agree to immediately notify the General Counsel of any pending or threatened litigation which relates to Your sales practices, or that of Your Sub-producers or employees involving the sales of
any of the Company’s products. 
  

					
	OL2650B 8-98	  	6	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

	7.	REPLACEMENTS 

 In most
instances, a replacement is not to the advantage of the policy or annuity holder because of; 
  

	 	(1)	increased premiums for a new policy issued at an older age, 

  

	 	(2)	duplication of acquisition costs, 

  

	 	(3)	loss of privileges and options under old policies or annuities, which in some instances are not available to the new ones, and 

  

	 	(4)	the introduction of new suicide and incontestability clauses. 

 Rarely will You encounter situations where replacement of permanent insurance or annuities in any Company will be advisable and in the best interest of the policyholder. If any replacement does occur, You
shall maintain files and records demonstrating to the Company’s satisfaction that the replacement is in the best interest of the policyholder. 
 The Company does not sanction the practice of seeking replacements or utilizing cash values of existing policies or annuities, which in most cases leads to ultimate surrender or lapse, as methods of
promoting the sale of new insurance. Any pattern of such activities on Your part, as determined by the Company, shall be the basis for immediate termination of this contract. 
 If You improperly induce policy, account or annuity holders of the Company to replace insurance or annuities in force in the Company with any
insurance or annuities issued by this or another Company, then in addition to any specific rights found elsewhere in this entire contract, then all Your rights to any compensation payable under the terms of this contract or any other contract with
the Company shall immediately cease. 
  

					
	OL2650B 8-98	  	7	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 BUSINESS ENTITY PROVISIONS 
  

	1.	INTRODUCTION AND AUTHORITY 

 If You are a partnership, corporation, or are an individual that has employees, all applications for the products offered under this contract shall be solicited only by individuals (hereinafter “Sub-producers”) representing You
who have been duly licensed under the applicable insurance laws to secure such applications and who indicate on each such application that it has been solicited on Your behalf. 
 If You are a corporation or a partnership, personal production under this contract shall be the production of the designated principal of the
corporation. 
  

	2.	CONDUCT 

 You will cause
and require all employees or Sub-producers associated with You to comply with all applicable state and federal laws and the regulations or other directives of the insurance departments of the states in which You are soliciting insurance including
the procurement of all prescribed licenses. 
 You will cause and require all employees or Sub-producers associated with You to
comply with the rules and regulations of the SEC; the rules of the NASD; the rules of the Broker-Dealer with which You are associated, and the Interagency Statement on Retail Sales of Nondeposit Investment Products issued by Federal banking
regulators on February 15, 1994 also known as the “Interagency Statement” as may be amended from time to time. 
 You will also cause and require all employees or Sub-producers associated with You to become familiar and comply with the terms of this Contract and all compliance and/or market conduct directives, manuals, guidelines that may be issued
from time to time by the Company. 
  

	3.	CONTRACTING OF SUB-PRODUCERS 

  

	 	(a)	If You are so authorized, You may recruit Sub-producers satisfactory to the Company to carry out the purposes of this contract. All such Sub-producers shall be approved
in writing by the Company and be appropriately licensed with the Company before entering into any contractual relationship with You. 

  

	 	(b)	The Company shall retain the authority to terminate or cancel any license of such Sub-producer of Yours, Any such Sub-producer whose license has been terminated or
canceled by the Company shall not perform any duties for You which involve Phoenix products or policyholders. 

  

	 	(c)	You shall be responsible to the Company for all business done or entrusted to Sub-producers or others appointed or employed by You, and no such appointee, Sub-producer
or employee shall have any claim against the Company for commissions or otherwise. 

  

	 	(d)	You shall indemnify and save the Company harmless from all losses, expenses, costs, damages and liability resulting from negligent acts by You or Your employees or
Sub-producers, and from acts or transactions by any of them not authorized by the Company. 

  

	 	(e)	Subject only to paragraphs (a), (b), (c), and (d) herein, You shall have the sole discretion in determining who among Your Sub-producers and employees shall
perform the functions required of You. 

  

	4.	DESIGNATION OF PRINCIPAL/GUARANTEES 

 If You are a partnership or corporation You shall designate by written resolution of Your Board of Directors or all partners, an executive officer or partner who is acceptable to the Company and
authorized to act in Your name in all matters with the Company, You agree to be bound by the acts of the principal and the principals’ transaction with the Company, and the Company may rely on the authority of the principal until the
principal’s designation as principal is revoked in writing by a resolution of Your Board of Directors or remaining partners and that resolution is filed by the Company. 
 In addition, if You are a corporation, the Company may require the principals of said corporation to execute a written guarantee of
performance of all terms of this contract by the corporation. 
  

					
	OL2650C 12-99	  	8	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 VARIABLE PRODUCTS PROVISIONS 
  

	1.	THE BROKER-DEALER 

 At
all times during the continuance of this Contract You, or the Broker-Dealer with which You are a registered representative, must be a registered broker-dealer with the SEC, a member of the NASD, and You, or the Broker-Dealer of which You are a
registered representative, must have a Broker-Dealer Supervisory and Service Agreement in effect with Phoenix Equity Planning Corporation (hereinafter “PEPCO”), the master servicer of the Variable Contracts, as defined by the Company, and
issued by the Company. 
  

	2.	REGISTRATION AND LICENSING 

  

	 	(a)	When soliciting applications for, or selling, Variable Contracts, You must at all times be a registered Broker-Dealer or a registered representative of, or associated
with, a registered Broker-Dealer, and if the particular jurisdiction requires, be licensed or registered as a representative of the Broker-Dealer. 

  

	 	(b)	When soliciting for, or selling, the Variable Contracts, You must at all times be validly licensed or appointed by the Company as a variable contracts producer in
accordance with the jurisdictional requirements of the place where the solicitations take place. 

  

	 	(c)	You may solicit for and sell the Variable Contracts wherever the Variable Contracts are authorized for sale by the governmental authorities having jurisdiction,
provided You, the Broker-Dealer with whom you are associated, and the Company are all validly licensed, registered or otherwise qualified, as required for the solicitation and sales of the Variable Contracts. 

  

	 	(d)	If You are a partnership, corporation, or an individual who has employees, any solicitation of applications must be by Sub-producers acting on Your behalf who: 1) have
been duly licensed to solicit applications for the Company; 2) have indicated on each application that the application is on Your behalf; 3) have been approved as Sub-producers in writing by the Company, 4) and are duly registered with the NASD. The
Company shall retain the authority to terminate the Sub-producer’s appointment with the Company. You shall be responsible for all business written by Sub-producers or employees, and they shall not have any direct claim against the Company,
PEPCO or Broker-Dealer (unless you are the Broker-Dealer) for commissions or other compensation. You shall be responsible for supervising all Sub-producers and employees and causing them to comply with the provisions of this Agreement.

  

	3.	AUTHORITY TO SOLICIT 

 Your authority to solicit Variable Contracts shall be immediately terminated if You cease to be validly NASD registered or the Broker-Dealer with which you are registered ceases to have a Broker-Dealer Supervisory and Service Agreement for
the Contracts in effect or it ceases to be SEC or NASD registered. 
  

	4.	COMPENSATION - VARIABLE LIFE AND ANNUITY PRODUCTS 

 The Company will pay to You commissions on Variable Products, as defined by the Company, for which You have secured the application and performed such other duties as may be necessary to place the policy
or annuity in force and have complied with the Company’s rules and procedures concerning the delivery of the policy or annuity. These commissions shall be as provided in this contract and in accordance with the commission schedule in force at
the time the policy is issued. 
 You agree that first year commissions related to sales of authorized Variable Contracts for
which You have placed in force will be paid to you. You direct and authorize that any first year commission due You be paid to You if You are a Broker-Dealer or the Broker-Dealer with whom you are associated if You are not a Broker-Dealer.

 The amount of first year commission You shall receive from the Broker-Dealer, as paying agent, shall be determined in
accordance with your agreement with the Broker-Dealer applicable to the Variable Contracts at the time a premium or a purchase payment is received by the Company. You agree that neither the Company nor PEPCO are responsible for your first year
commission and that You shall look to and seek such compensation only from the Broker-Dealer with whom You are associated. 
  

					
	OL2650D 12-99	  	9	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 Compensation, other than first year commissions, shall be paid by the Company directly to
You in accordance with the applicable Schedule attached hereto. 
 You shall not be entitled to any compensation based on
premiums and/or purchase payments received by the Company after termination of this Contract, except as specified in the applicable Schedule attached hereto. 
 Should the Company for any reason refund any premium on any Contract sold hereunder including, but not limited to, any premiums refunded under any free look provision, You shall repay on demand any
compensation received with respect thereto. 
 If You are soliciting sales of Variable Products as a Sub-producer of a
Broker-Dealer which is insurance licensed and has a Contract with the Company, all compensation under this Contract will be paid to that Broker-Dealer. 
  

	5.	PREMIUM AND COMMISSION REGULATIONS 

 First year premiums are those paid for the first policy year. Renewal premiums are those paid for each subsequent policy year, referred to herein as a renewal year. First year commissions are those
payable on first year premiums. Renewal commissions are those payable on renewal premiums. Commissions will be payable on interim premiums, extra premiums, or waived premiums as provided by the rules of the Company as then in force. 
 For the purpose of this contract, a premium shall be regarded as paid in the calendar year in which it is entered as paid in the accounting
records of the Company in its Home Office. 
  

	6.	FIRST YEAR COMMISSIONS 

 First year commissions on policies will be paid in accordance with such schedule on first year premiums paid on business produced by You as described above and herein. 
  

	7.	RENEWAL COMMISSIONS 

 Renewal commissions will be paid on renewal premiums of such business according to the schedule in force at the time of the payment of first year premium, and, except as specifically stated herein, shall be governed by the rules of the
Company as then in force. 
  

	8.	VESTED RENEWAL COMMISSIONS 

 Commissions that are vested will be paid whether or not this contract has been terminated at the time the premium is paid on which the commission is based. The vested commission payable on any product is determined from the commission
schedule in force at the time the first year premium payment was made. This commission as earned in accordance with this contract, will be payable to You, or, if You are an individual and are deceased, to Your executor or administrator. 

 

	9.	JOINT SUBMISSION 

 If
business is submitted jointly by more than one producer, subject to the approval of the Company, the division of commissions will be proportionate, or in accordance with directions in the application submitted. 
  

	10.	REPLACEMENT OR REWRITE OF POLICIES 

  

	 	(a)	Replacement 

 When a policy is
issued to take the place of another policy in this or any other insurance company, the commission on the new policy, if allowed, shall be governed by the rules of the Company as then in force. 
  

	 	(b)	Refund of Premium 

 Should the
Company for any reason refund any premium on any policy sold or annuity hereunder, You shall repay on demand any commissions or any other compensation received therein, including, but not limited to, the refund of any premiums under any Free Look
Provision. You shall also refund any advanced commissions or other compensation which became unearned because of non-payment of premiums. 
  

	 	(c)	Reduction or Modification 

 If,
before the end of the second policy year, the policy is reduced in amount or is divided into two or more policies so that one or more policies are written on which the rate of the first year commissions in accordance with the standard commission
schedule would have been less than was actually paid thereunder, then the excess first year commission, renewal commissions or any other compensation over the respective amounts due on said changed policy or policies shall be returned to the
Company. 
 This provision shall not be impaired by the termination of this contract. 
  

					
	OL2650D 12-99	  	10	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

	11.	LAPSE OR TERMINATION 

 If
any policy sold by You is lapsed, terminated, or not taken, no commission thereafter shall be payable to You unless You are wholly instrumental in restoring it while You are acting hereunder and within three (3) months of the lapse or
cancellation. 
  

	12.	EXPENSE ALLOWANCE PROVISIONS 

 The Company will provide You an allowance to offset expenses You have incurred in soliciting and placing insurance and annuity contracts with the Company. 
  

	 	(a)	The Company agrees, subject to limitations and conditions herein described and to the extent permitted by appropriate regulatory authorities, to make periodic Expense
Allowance Payments to You. The Expense Allowance Payments shall be made in accordance with the Expense Allowance Schedule in effect at the time the payment is earned. The Expense Allowance Schedule currently in force is attached to and made a part
of this Agreement. 

  

	 	(b)	To be eligible to receive Expense Allowance Payments in any calendar year, You must meet the requirements set forth in the current Expense Allowance Schedule.

  

	 	(c)	Expense Allowance Payments are not to be used to effect compensation or allowances in excess of the limits permitted by any law or regulation. In the event the Company
determines that a payment or payments is, or was, in excess of those limitations, You agree to refund such amounts upon demand of the Company. 

  

	 	(d)	These provisions or the Expense Allowance Schedule may be modified in whole or in part from time to time through standard Company communications procedures. Any
modifications of this Agreement or the expense Allowance Schedule made after the date on this Agreement or the attached Schedule shall govern. Such modifications are available for inspection at the Company’s local field offices.

  

	 	(e)	In the event the Company makes Expense Allowance Payments to which You are not entitled under the terms of this Contract and Schedule attached hereto, You agree to
refund any amounts due the Company promptly upon demand by the Company. The Company shall have the right to set off amounts due You under this Agreement against any amounts You owe the Company, its affiliates and/or subsidiaries. The terms of this
provision shall not be impaired by termination of this Agreement. 

  

	 	(f)	No Expense Allowance payments will be paid to You if Your Broker-Dealer has an Expense Allowance Agreement or Commission Contract with the Company.

  

	13.	REGULATORY COMPLIANCE 

 If
any compensation provision of this contract is disapproved by any regulatory authority, this contract may be modified as necessary to be acceptable to such regulators. The effective date of such modification may be retroactive to the date of this
contract or such other date that may be required by such regulators. You agree to promptly refund upon demand any compensation paid in excess of any amount approved by said regulatory authority. 
  

					
	OL265OD 12-99	  	11	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 PROVISIONS FOR CONTRACTING OF PRODUCERS 
  

	1.	CONDUCT 

 You will cause
and require all Producers, employees or Sub-producers associated with You to comply with all federal or state laws, statutes and regulations or directives issued by any regulatory entity having jurisdiction in this matter, the procurement of all
prescribed licenses and including without limitation the rules and regulations of the SEC; the rules of the NASD; the rules of the Broker-Dealer with which You are associated; the Interagency Statement on Retail Sales of Nondeposit Investment
Products issued by Federal banking regulators on February 15, 1994 also known as the “Interagency Statement” as may be amended from time to time. 
  

	2.	CONTRACTING OF PRODUCERS 

  

	 	(a)	If You are so authorized, You may recruit Producers satisfactory to the Company to carry out the purposes of this contract. All such agents shall be approved in writing
by the Company and be appropriately licensed and contracted with the Company before entering into any contractual relationship with You. 

  

	 	(b)	The Company shall retain the authority to terminate and cancel any license and contract of such Producer and any such Producer whose license or contract has been
terminated or canceled by the Company shall not perform any duties for You which involve products or policyholders of the Company. 

  

	 	(c)	All such Producers shall be appropriately licensed with the Company and shall execute a standard commission contract with the Company. 

  

	 	(d)	The term Producer when used in this contract shall mean any Producer contracted by the Company as a result of the written recommendation by You or assigned by the
Company to You for supervision. 

  

	 	(e)	You shall be responsible to the Company for all business done or entrusted to Producers and no such Producer shall have any claim against the Company for commissions or
otherwise unless in accordance of the terms of the standard commission contract by the Company and the Producer. 

  

	 	(f)	You shall indemnify and save the Company harmless from all losses, expenses, costs, damages and liability resulting from negligent acts by You or Your agents and from
acts or transactions by any of them not authorized by the Company. 

  

	 	(g)	Subject only to paragraphs (a), (b), (c), and (d) herein, You shall have the sole discretion in determining who among Your Producers shall perform the functions
required of You. 

  

					
	OL2650F 8-98	  	12	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

 COMPENSATION PROVISIONS 
  

	1.	COMPENSATION - TRADITIONAL LIFE AND ANNUITIES 

 The Company will pay to You commissions on policies and annuities for which You have secured the application and performed such other duties as may be necessary to place the policy or annuity in force and
have complied with the Company’s rules and procedures concerning the delivery of the policy or annuity. These commissions shall be as provided in this contract and in accordance with the commission schedule in force at the time the policy is
issued. 
  

	2.	PREMIUM AND COMMISSION REGULATIONS 

 First year premiums are those paid for the first policy year. Renewal premiums are those paid for each subsequent policy year, referred to herein as a renewal year. First year commissions are those
payable on first year premiums. Renewal commissions are those payable on renewal premiums. Commissions will be payable on interim premiums, extra premiums, or waived premiums as provided by the rules of the Company as then in force. 
 For the purpose of this contract, a premium shall be regarded as paid in the calendar year in which it is entered as paid in the accounting
records of the Company in its Home Office. 
  

	3.	FIRST YEAR COMMISSIONS 

 First year commissions on policies will be paid in accordance with such schedule on first year premiums paid on business produced by You as described above and herein. 
  

	4.	RENEWAL COMMISSIONS 

 Renewal commissions will be paid on renewal premiums of such business according to the schedule in force at the time of the payment of first year premium, and, except as specifically stated herein, shall be governed by the rules of the
Company as then in force. 
  

	5.	VESTED RENEWAL COMMISSIONS 

 Commissions that are vested will be paid whether or not this contract has been terminated at the time the premium is paid on which the commission is based. The vested commission payable on any product is determined from the commission
schedule in force at the time the first year premium payment was made. This commission, as earned in accordance with this contract, will be payable to You, or, if You are an individual and are deceased, to Your executor or administrator. 

 

	6.	JOINT SUBMISSION 

 If
business is submitted jointly by more than one producer, subject to the approval of the Company, the division of commissions will be proportionate, or in accordance with directions in the application submitted. 
  

	7.	REPLACEMENT OR REWRITE OF POLICIES 

  

	 	(a)	Replacement 

 When a policy is
issued to take the place of another policy in this or any other insurance company, the commission on the new policy, if allowed, shall be governed by the rules of the Company as then in force. 
  

	 	(b)	Refund of Premium 

 Should the
Company for any reason refund any premium on any policy sold or annuity hereunder, You shall repay on demand any commissions or any other compensation received therein, including, but not limited to, the refund of any premiums under any Free Look
Provision. You shall also refund any advanced commissions or other compensation which became unearned because of non-payment of premiums. 
  

	 	(c)	Reduction or Modification 

 If,
before the end of the second policy year, the policy is reduced in amount or is divided into two or more policies so that one or more policies are written on which the rate of the first year commissions in accordance with the standard commission
schedule would have been less than was actually paid thereunder, then the excess first year commission, renewal commissions or any other compensation over the respective amounts due on said changed policy or policies shall be returned to the
Company. 
  

					
	OL2650E 6-01	  	13	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

	 	(d)	Termination under Policy Rider 

 If a policy sold by You is lapsed, surrendered, canceled or otherwise terminated by the policyholder by exercising a right given the policyholder by the terms of any rider to the policy, all compensation paid on the policy shall be returned
to the Company. 
  

	 	(e)	Surrender, Death or Termination in the First Year 

 If during the first policy year the annuity policy is terminated by reason of death, free look or total surrender, all compensation paid on the policy shall be returned to the Company. 
 If during the first policy year of the annuity policy there is a partial surrender in excess of any penalty free surrender amount, the
compensation on that excess amount shall be returned to the Company. 
 This provision shall not be impaired by the termination
of this contract. 
  

	8.	LAPSE OR TERMINATION 

 If
any policy sold by You is lapsed, terminated, or not taken, no commission thereafter shall be payable to You unless You are wholly instrumental in restoring it while You are acting hereunder and within three (3) months of the lapse or
cancellation. 
  

	9.	EXPENSE ALLOWANCE PROVISIONS 

 The Company will provide You an allowance to offset expenses You have incurred in soliciting and placing insurance and annuity contracts with the Company. 
  

	 	(a)	The Company agrees, subject to limitations and conditions herein described and to the extent permitted by appropriate regulatory authorities, to make periodic Expense
Allowance Payments to You. The Expense Allowance Payments shall be made in accordance with the Expense Allowance Schedule in effect at the time the payment is earned. The Expense Allowance Schedule currently in force is attached to and made a part
of this Agreement. 

  

	 	(b)	To be eligible to receive Expense Allowance Payments in any calendar year, You must meet the requirements set forth in the current Expense Allowance Schedule.

  

	 	(c)	Expense Allowance Payments are not to be used to effect compensation or allowances in excess of the limits permitted by any law or regulation. In the event the Company
determines that a payment or payments is, or was, in excess of those limitations, You agree to refund such amounts upon demand of the Company. 

  

	 	(d)	These provisions or the Expense Allowance Schedule may be modified in whole or in part from time to time through standard Company communications procedures. Any
modifications of this Agreement or the expense Allowance Schedule made after the date on this Agreement or the attached Schedule shall govern. Such modifications are available for inspection at the Company’s local field offices.

  

	 	(e)	In the event the Company makes Expense Allowance Payments to which You are not entitled under the terms of this Contract and Schedule attached hereto, You agree to
refund any amounts due the Company promptly upon demand by the Company. The Company shall have the right to set off amounts due You under this Agreement against any amounts You owe the Company, its affiliates and/or subsidiaries. The terms of this
provision shall not be impaired by termination of this Agreement. 

  

	 	(f)	No Expense Allowance payments will be paid to You if Your Broker-Dealer has an Expense Allowance Agreement or Commission Contract with the Company.

  

	10.	REGULATORY COMPLIANCE 

 If
any compensation provision of this contract is disapproved by any regulatory authority, this contract may be modified as necessary to be acceptable to such regulators. The effective date of such modification may be retroactive to the date of this
contract or such other date that may be required by such regulators. You agree to promptly refund upon demand any compensation paid in excess of any amount approved by said regulatory authority. 
  

					
	OL2650E 6-01	  	14	  	© 2001 Phoenix Life Insurance Company - All Rights Reserved

					
	

	  	 Phoenix Life Insurance Company
 100 Bright Meadow Boulevard
 PO Box 1900
 Enfield CT 06083-1900
	  	EAP-A

 Expense Allowance Schedule 
 You are responsible for all payment of expenses in Your office. The Company will pay an expense allowance to You to offset the expenses You have incurred in the acquisition and servicing of insurance
contracts placed through Your office. Payment of the expense allowance is as follows: 
  

	1.	Definitions 

  

	 	a.	Eligible First Year Commissions (FYC) are defined as follows: 

  

	 	•	 	 FYC on annual premium of individual variable life insurance plans, other than traditional universal life insurance plans: and

	 	•	 	 FYC on premium up to the commissionable target premium (CTP) for flexible premium variable universal life plans. 

  

	 	b.	Eligible FYC do not include the following: FYC on premium in excess of the commissionable premium (CTP) for flexible premium variable universal life, or on any
product the company may from time to time exclude. 

  

	 	c.	Eligible FYC year-to-date include all of Your eligible FYC which have been earned and paid during the current calendar year, including the current commission cycle.

  

	2.	Expense Allowance Payment (EAP) Calculation 

 The Company will calculate and pay EAP as a percentage of Eligible FYC at 82% for all business paid during the current calendar. 
 Eligible FYC shall be regarded as paid when the premium is entered as paid in the accounting records of the Company in its home office. 
  

					
	OL2720B	  	15	  	4-01

					
	

	  	 Phoenix Life Insurance Company
 100 Bright Meadow Boulevard
 PO Box 1900
 Enfield CT 06083-1900
	  	EAP-4

  

	B.	Expense Allowance Schedule 

 You are
responsible for all payment of expenses in Your office. The Company will pay an expense allowance to You to offset the expenses You have incurred in the acquisition and servicing of insurance contracts placed through Your office. Payment of the
expense allowance is as follows: 
  

	1.	Definitions 

  

	 	a.	Eligible First Year Commissions (FYC) are defined as follows: 

  

	 	•	 	 FYC on annual premium of individual life insurance plans, other than universal life. 

	 	•	 	 FYC on premium up to the commissionable target premium (CTP) for flexible premium universal life plans. 

	 	•	 	 Eligible FYC do not include the following: FYC on variable life plans, FYC on PAPOR, FYC on premium in excess of the commissionable premium (CTP) for
flexible premium universal life, including variable universal life or FYC on any product the company may from time to time exclude. 

	 	b.	Eligible FYC year-to-date include all of your eligible FYC which have been earned and paid during the current calendar year, including the current commission cycle.

  

	2.	Expense Allowance Payment (EAP) Calculation 

 The Company will calculate and pay EAP as a percentage of Eligible FYC for all business paid during the current calendar year as follows: 
  

			
	Eligible First Year Commissions YTD	  	Expense Allowance
	0-24,999	  	40%
	25,000-74,999	  	50%
	75,000-149,999	  	60%
	150,000 and greater	  	70%

 Each pay period, Phoenix will calculate the expense allowance payment earned on a year-to-date basis
per the above schedule, subtract expense allowance paid to date, and pay the balance due. 
 Eligible FYC shall be regarded as paid when the
premium is entered as paid in the accounting records of the Company in its home office. 
 Your signature is acknowledgement of receipt and
understanding of the compensation payments outlined in this Schedule. 
  

					
		 	 ICC INSURANCE AGENCY, INC

		 	 
		 	 Producer Name
	  	
			
		 	[ILLEGIBLE SIGNATURE]	  	12/1/02
		 	 
		 	 Producer Signature
	  	Date
			
		 	 Dora D. Young
	  	
		 	 
		 	 For Phoenix life Insurance Company
                 PRESIDENT
	  	Date

  

					
	[ILLEGIBLE]	  		  	4-01

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00170-of-00352.parquet"}]]